COMPOUND: C05981
Help
Entry
C05981 Compound
Name
Phosphatidylinositol-3,4,5-trisphosphate;
1-Phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate;
1,2-Diacyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-bisphosphate)
Formula
C11H20O22P4R2
Structure
Mol file
KCF file
DB search
Comment
Generic compound in reaction hierarchy
Reaction
R04504
R04513
R04545
R09827
Pathway
map00562
Inositol phosphate metabolism
map01100
Metabolic pathways
map01521
EGFR tyrosine kinase inhibitor resistance
map04012
ErbB signaling pathway
map04014
Ras signaling pathway
map04062
Chemokine signaling pathway
map04068
FoxO signaling pathway
map04070
Phosphatidylinositol signaling system
map04071
Sphingolipid signaling pathway
map04072
Phospholipase D signaling pathway
map04140
Autophagy - animal
map04144
Endocytosis
map04150
mTOR signaling pathway
map04151
PI3K-Akt signaling pathway
map04152
AMPK signaling pathway
map04210
Apoptosis
map04211
Longevity regulating pathway
map04212
Longevity regulating pathway - worm
map04213
Longevity regulating pathway - multiple species
map04218
Cellular senescence
map04370
VEGF signaling pathway
map04510
Focal adhesion
map04611
Platelet activation
map04613
Neutrophil extracellular trap formation
map04650
Natural killer cell mediated cytotoxicity
map04660
T cell receptor signaling pathway
map04662
B cell receptor signaling pathway
map04664
Fc epsilon RI signaling pathway
map04666
Fc gamma R-mediated phagocytosis
map04722
Neurotrophin signaling pathway
map04810
Regulation of actin cytoskeleton
map04910
Insulin signaling pathway
map04914
Progesterone-mediated oocyte maturation
map04917
Prolactin signaling pathway
map04919
Thyroid hormone signaling pathway
map04926
Relaxin signaling pathway
map04931
Insulin resistance
map04960
Aldosterone-regulated sodium reabsorption
map04973
Carbohydrate digestion and absorption
map05010
Alzheimer disease
map05131
Shigellosis
map05132
Salmonella infection
map05135
Yersinia infection
map05142
Chagas disease
map05145
Toxoplasmosis
map05160
Hepatitis C
map05162
Measles
map05163
Human cytomegalovirus infection
map05164
Influenza A
map05165
Human papillomavirus infection
map05166
Human T-cell leukemia virus 1 infection
map05167
Kaposi sarcoma-associated herpesvirus infection
map05168
Herpes simplex virus 1 infection
map05169
Epstein-Barr virus infection
map05170
Human immunodeficiency virus 1 infection
map05200
Pathways in cancer
map05207
Chemical carcinogenesis - receptor activation
map05208
Chemical carcinogenesis - reactive oxygen species
map05210
Colorectal cancer
map05212
Pancreatic cancer
map05213
Endometrial cancer
map05214
Glioma
map05215
Prostate cancer
map05218
Melanoma
map05220
Chronic myeloid leukemia
map05221
Acute myeloid leukemia
map05222
Small cell lung cancer
map05223
Non-small cell lung cancer
map05224
Breast cancer
map05225
Hepatocellular carcinoma
map05226
Gastric cancer
map05231
Choline metabolism in cancer
map05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
map05415
Diabetic cardiomyopathy
map05417
Lipid and atherosclerosis
Network
nt06160
Human T-cell leukemia virus 1 (HTLV-1)
nt06161
Human immunodeficiency virus 1 (HIV-1)
nt06162
Hepatitis B virus (HBV)
nt06163
Hepatitis C virus (HCV)
nt06164
Kaposi sarcoma-associated herpesvirus (KSHV)
nt06165
Epstein-Barr virus (EBV)
nt06166
Human papillomavirus (HPV)
nt06167
Human cytomegalovirus (HCMV)
nt06168
Herpes simplex virus 1 (HSV-1)
nt06169
Measles virus (MV)
nt06170
Influenza A virus (IAV)
nt06181
Salmonella
nt06182
Shigella
nt06214
PI3K signaling (cancer)
nt06224
CXCR signaling (cancer)
nt06260
Colorectal cancer
nt06261
Gastric cancer
nt06262
Pancreatic cancer
nt06263
Hepatocellular carcinoma
nt06264
Renal cell carcinoma
nt06266
Non-small cell lung cancer
nt06267
Small cell lung cancer
nt06268
Melanoma
nt06270
Breast cancer
nt06271
Endometrial cancer
nt06272
Prostate cancer
nt06273
Glioma
nt06275
Acute myeloid leukemia
nt06276
Chronic myeloid leukemia
nt06462
Spinocerebellar ataxia
nt06464
Amyotrophic lateral sclerosis
nt06530
PI3K signaling
nt06537
TCR/BCR signaling
nt06541
Cytoskeleton in neurons
nt06543
NRG-ERBB signaling
Enzyme
2.7.1.153
3.1.3.36
3.1.3.67
3.1.3.86
Brite
Lipids [BR:
br08002
]
GP Glycerophospholipids
GP09 Glycerophosphoinositol trisphosphates
GP0901 Diacylglycerophosphoinositol trisphosphates
C05981 1,2-Diacyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-bisphosphate)
BRITE hierarchy
Other DBs
PubChem:
8260
LinkDB
All DBs
KCF data
Show
ATOM 39
1 O1c O 26.0886 -23.8676
2 P1b P 27.4862 -23.8618
3 O1c O 28.8802 -23.8618
4 O2b O 27.4862 -22.4667
5 O1c O 27.4862 -25.2570
6 P1b P 30.1416 -16.8696
7 O2b O 30.1359 -18.2607
8 O1c O 28.7492 -16.8753
9 O1c O 30.1359 -15.4700
10 O1c O 31.5410 -16.8696
11 C1y C 28.7058 -18.9618
12 C1y C 28.7058 -20.3645
13 C1y C 27.4862 -18.2756
14 C1y C 27.4862 -21.0754
15 O2b O 29.9137 -21.0637
16 C1y C 26.2911 -18.9618
17 O1a O 27.4862 -16.8843
18 C1y C 26.2911 -20.3645
19 P1b P 31.3073 -21.0580
20 O2b O 25.0747 -18.2614
21 O1a O 25.0832 -21.0580
22 O1c O 32.6985 -21.0580
23 O1c O 31.3073 -19.6667
24 O1c O 31.3073 -22.4574
25 P1b P 23.6836 -18.2497
26 O2b O 22.2840 -18.2497
27 O1c O 23.6893 -16.8503
28 O1c O 23.6777 -19.6410
29 C1b C 22.2840 -16.8535
30 C1c C 21.0768 -16.1592
31 C1b C 21.0768 -14.7702
32 O7a O 19.8754 -16.8535
33 O7a O 22.2840 -14.0703
34 C7a C 18.6668 -16.1521
35 C7a C 22.2840 -12.6751
36 O6a O 18.6668 -14.7631
37 R R 17.4655 -16.8464
38 O6a O 21.0698 -11.9869
39 R R 23.4994 -11.9798
BOND 39
1 11 13 1
2 12 14 1
3 12 15 1 #Down
4 13 16 1
5 13 17 1 #Down
6 14 18 1
7 14 4 1 #Up
8 15 19 1
9 16 20 1 #Up
10 18 21 1 #Up
11 19 22 1
12 19 23 1
13 19 24 2
14 20 25 1
15 25 26 1
16 25 27 1
17 25 28 2
18 16 18 1
19 2 4 1
20 2 5 2
21 1 2 1
22 2 3 1
23 6 7 1
24 6 8 2
25 6 9 1
26 6 10 1
27 11 7 1 #Up
28 11 12 1
29 26 29 1
30 29 30 1
31 30 31 1
32 30 32 1 #Down
33 31 33 1
34 32 34 1
35 33 35 1
36 34 36 2
37 34 37 1
38 35 38 2
39 35 39 1
» Japanese version
DBGET
integrated database retrieval system